Loading clinical trials...
Loading clinical trials...
This study seeks to screen first degree family members of people with Idiopathic Pulmonary Fibrosis (IPF) for the earliest signs of lung fibrosis.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Colorado, Denver
NCT07466420 · Fibrotic Interstitial Lungs Diseases, Idiopathic Pulmonary Fibrosis (IPF), and more
NCT07332117 · Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis
NCT05975983 · Idiopathic Pulmonary Fibrosis (IPF)
NCT04598919 · Idiopathic Pulmonary Fibrosis (IPF)
NCT07119099 · Idiopathic Pulmonary Fibrosis (IPF)
University of Colorado Anschutz Medical Campus
Aurora, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions